Nivolumab & relatlimab-rmbw
Opdualag
3mg/1mg
J9298
Immunotherapy
Checkpoint Inhibitor
Monoclonal Antibody
PD-1
LAG3
No
2022
 
Sept. 27, 2022
 
In Use